Delivery Order SPE2DB24D3013-SPE2DB24FFHRF

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,954.76 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 Gram Capsule 120S, a cardiovascular medication. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,115.61 firm fixed price delivery order is for the supply of 120-count bottles of the pharmaceutical product Icosapent Ethyl 1 gram capsules. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corporation with DLA,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565550845 Icosapent Ethyl 1 gram capsule bottles. The contract has a total ceiling value of $1,668.12 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025. This IDC enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Icosapent Ethyl 1 Gram Capsule 120s, with a ceiling value of $2,053.92 and a completion date of June 10, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,370.64 delivery order is for the supply of icosapent ethyl 1 gram capsules, a cardiovascular medication. This award is under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The contract has a ceiling value of $1,468.09 and runs through February 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $1,302.16 and a period of performance extending through June 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $2,294.22, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price delivery order. The award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a significant supplier of medical...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHRF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,105.76 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules, with a completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/9/24, 1:47 PM